Price
620.25
-3.54%52W Range
Market Cap
₹356.46 Cr
Traded: ₹0.08 Cr (0.02%) 0.0x
Free Float: ₹104.19 Cr (0.08% of FF traded)
Volume · 60D trend
1.31 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -8.0% | -- | +14.0% | Accelerating |
| Profit | -- | -- | -41.0% | -- | +389.0% | Accelerating |
| Return | -- | -- | -- | -4.0% | -- | -- |
| ROE | -- | -- | +2.0% | -- | -- | -- |
Quarterly Results
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 96 | 86 | 69 | 68 | 67 | 74 | 62 | 77 | 74 | 88 | 84 | 82 | 80 | 88 |
| Expenses | 84 | 71 | 62 | 64 | 62 | 76 | 59 | 73 | 64 | 79 | 74 | 73 | 69 | 70 |
| Operating Profit | 12 | 15 | 7 | 5 | 5 | -2 | 3 | 4 | 10 | 9 | 9 | 9 | 10 | 19 |
| OPM % | 12.7% | 17.4% | 10.1% | 6.6% | 7.2% | -3.2% | 5.2% | 5.3% | 13.8% | 10.3% | 11.3% | 11.0% | 12.7% | 21.3% |
| Other Income | 2 | 1 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | 0 | 1 | 2 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit Before Tax | 9 | 11 | 2 | 1 | 1 | -8 | -2 | 1 | 7 | 4 | 5 | 6 | 6 | 14 |
| Tax % | 25.3% | 13.4% | -2.8% | 39.7% | 34.6% | -17.0% | -24.1% | 26.1% | 25.4% | 25.7% | 10.8% | 25.7% | 25.7% | 23.7% |
| Net Profit | 7 | 9 | 2 | 0 | 1 | -6 | -2 | 1 | 5 | 3 | 5 | 4 | 5 | 11 |
| Exceptional Items | -- | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 11.5 | 16.1 | 3.2 | 0.7 | 1.6 | -11.3 | -2.6 | 1.2 | 8.8 | 5.3 | 8.3 | 7.7 | -- | -- |
| Sales Growth (YoY) | 44.1% | 16.3% | 11.2% | -11.3% | -9.9% | -16.3% | -25.7% | -5.8% | -7.0% | -0.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 12.1% | 24.0% | 1.2% | 2.5% | -9.6% | 18.6% | -19.3% | 4.1% | -15.9% | 5.3% | 2.3% | 2.9% | -9.9% | -- |
| OP Growth (YoY) | 153.7% | 733.2% | 116.4% | 9.2% | -52.8% | -126.0% | -65.7% | -54.4% | 1.0% | -51.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | -17.8% | 112.9% | 55.3% | -6.6% | 305.1% | -172.8% | -21.6% | -59.6% | 13.1% | -4.1% | 4.3% | -10.7% | -46.1% | -- |
| Profit Growth (YoY) | -- | 222.0% | 257.0% | -43.0% | -82.0% | -311.0% | -132.0% | -85.0% | 12.0% | -72.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 641.9% | 242.3% | 220.4% | -42.4% | -82.5% | -311.4% | -131.8% | -84.7% | -- | -- | -- | -- | -- | -- |
| EPS Growth (QoQ) | -28.4% | 405.0% | 367.6% | -56.1% | 113.7% | -327.6% | -323.7% | -86.7% | 65.5% | -35.7% | 7.7% | -- | -- | -- |
| OP Margin | 12.7% | 17.4% | 10.1% | 6.6% | 7.2% | -3.2% | 5.2% | 5.3% | 13.8% | 10.3% | 11.3% | 11.0% | 12.7% | 21.3% |
| Net Margin | 6.9% | 10.8% | 2.6% | 0.6% | 1.3% | -8.8% | -2.5% | 0.9% | 6.9% | 3.5% | 5.7% | 5.4% | 5.7% | 12.2% |
| Material Cost % | -- | 42.0% | 46.1% | 47.3% | 49.1% | 63.7% | 45.4% | 52.1% | 44.5% | 53.7% | 43.2% | 48.1% | 47.8% | 46.0% |
| Employee Cost % | -- | 8.9% | 9.3% | 7.8% | 10.6% | 9.2% | 12.9% | 9.7% | 10.6% | 8.4% | 9.1% | 8.8% | 8.1% | 8.3% |
| P/S | 1.12 | 1.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 19.74 | 30.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.98 | 0.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31, 2026, and Unaudited Financial results ....
The Board of Directors, at its meeting held on April 30, 2026, had recommend the final dividend 70%, being Rs. 7 per equity share of Rs. 10 each, for the financial year ended March 31, ....
Please find details of Book Closure of dates for Annual General meeting.
The Board has in its meeting held August 12, 2026, has recommended the reappointment of the Statutory Auditor of the Company.
Please find attached herewith Revised Financial results for the quarter and year ended March 31, 2026
Please find attached herewith unaudited financial results for quarter ended June 30, 2026
Please find attached herewith details of Annual general Meeting of the Company.
This is to inform you that the Board of Directors of the Company at their meeting held today i.e., on Wednesday August 12, 2026, have inter-alia, considered and approved the following: ....
This is to inform you that the Board of Directors of the Company at their meeting held today i.e., on Wednesday August 12, 2026, have inter-alia, considered and approved the following: ....
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve i. Revised Audited Financial ....
Please find attached resignation of Chief Information Officer of the Company.
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026, is enclosed herewith.
The Company has informed the Stock Exchange about the closure of Trading window.
Please find attached Annual Secretarial Compliance Report of the Company for financial year ended March 31, 2026
Please find attached clipping of Newspaper Publication.
Please find enclosed Board Meeting Outcome contains details of Dividend
The Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31, 2026
Please find attached Financial Results.
This is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e., on April 30, 2026, had inter-alia considered and approved the following ....
The Company hereby informs that The Board of Directors in its meeting held on April 30, 2026, has approved the appointment of Chief Financial Officer of the Company
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Certificate under regulation 74(5) of SEBI (DP) Regulations,2018 for the quarter ended March 31, 2026, is enclosed herewith.
The Company has informed the Stock Exchange about the closure of Trading window.
Newspaper Advertisement for the unaudited financial results of the company for the Quarter and Nine months ended December 31, 2025.
The Company has informed the Exchange about appointment of Company Secretary and Compliance Officer of the Company.
Please find attached Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
This is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e., on February 05, 2026, had inter-alia considered and approved the following: 1. ....
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
The Board Meeting to be held on 28/01/2026 Stands Cancelled.
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve unaudited financial results ....
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31 December 2025 is enclosed herewith.
The Company has informed the Stock Exchange about the closure of Trading window.
The Company hereby informs that the Board in its meeting held on December 18, 2025, have appointed Interim Chief Financial Officer of the Company effective December 18, 2025
Company hereby informs that the Company Secretary and Compliance officer has resigned w.e.f. 12th December 2025.
Newspaper Advertisement for the unaudited financial results of the Company for the Quarter ended and Half Year ended September 30, 2025.
Approval of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025
This is to inform you that the Board of Directors of National Peroxide Limited (formerly known as NPL Chemicals Limited) ('the Company') at their meeting held today i.e., on November 03, ....
National Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve unaudited financial results ....
Intimation regarding Revision of Credit rating in terms of Regulation 30 of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015.
Compliance under Regulation 74(5) SEBI (DP) Regulations, 2018 for the Quarter ended on 30th September 2025.
Pursuant to Regulation 30 SEBI (Listing obligations and Disclosure requirements) Regulation 2015, this is to inform you that Mr. Pravin Shetty Chief financial officer and Chief Risk Officer ....
The members in its 5th AGM held on September 04, 2025, had approved the appointment of Secretarial Auditor of the Company for the term of five years.
Pursuant to regulation 44 of SEBI (LODR) Regulations, 2015 Please find attached scrutinizer report along with voting results.
Summary of Proceedings of the 5th Annual General Meeting of the company held on September 04, 2025 at 03:30 p.m. IST through Video Conferencing.
outcome of the 5th Annual General Meeting of the Company held through video conferencing("VC)/ other Audio Visual Means("OAVM")
Newspaper publication of Notice to the members published in the Business Standard (English) and Mumbai Lakshadweep (Marathi) on Saturday i.e., 9th August, 2025.
Pursuant to Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a letter is being sent to those shareholders who have not registered their E-mail ....
Pursuant to Regulation 30 and 34 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. Please find attached the Annual Report for financial year ended 31st March ....
Notice of the 5th AGM of National Peroxide Limited Scheduled to be held on Thursday, September 04, 2025, at 03:30 p.m. (IST) through Video conferencing / Other Audio-visual Means.
Newspaper Advertisement of notice to the members published in Business standard (in English) and Mumbai Lakshadweep (in Marathi) on Thursday August 07, 2025.